Skip to main content
Retour
Watch Compare

BIOREGENX, INC.

Qualité des données : 100%
BRGX
OTC Technology IT Services
0,01 €
▼ 0,00 € (-12,61%)
Cap. Boursière: 11,44 M
Prix
0,01 €
Cap. Boursière
11,44 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -48 025,0
Capital efficient — spends only 0,31% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)10420,64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-980,96%
Op. Margin-965,35%

Sécurité

Debt / Equity
N/A
Current Ratio0,07
Interest Coverage-116,53

Valorisation

PE (TTM)
-0,60
En dessous de la moyenne du secteur (-0,16)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Technology (1068 pairs)
Métrique Action Médiane du Secteur
P/E -0,6 -0,2
P/B — 3,0
ROE % — 1,6
Net Margin % -981,0 -0,6
Rev Growth 5Y % — 7,2
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) 10420,64% Revenue Growth (3Y) 645,03%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,93 M Net Income (TTM) -18,93 M
ROE N/A ROA -1632,76%
Gross Margin 78,14% Operating Margin -965,35%
Net Margin -980,96% Free Cash Flow (TTM) -48 025,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,07
Interest Coverage -116,53 Asset Turnover 1,66
Working Capital -3,66 M Tangible Book Value -4,37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,60 Forward P/E N/A
P/B Ratio N/A P/S Ratio 5,93
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,42%
Market Cap 11,44 M Enterprise Value 11,44 M
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,31% FCF Conversion 0,25%
SBC-Adj. FCF -1,54 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 2,34 M 22 243,0 42 159,0
Net Income -23,05 M -571 171,0 -78 308,0
EPS (Diluted) -0,02 0,00 0,00
Gross Profit 1,66 M — 42 159,0
Operating Income -22,76 M -109 663,0 -78 308,0
EBITDA — — —
R&D Expenses 0,0 — —
SG&A Expenses 5,85 M — —
D&A 2,22 M — —
Interest Expense 6 638,0 8 276,0 —
Income Tax — 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 508 535,0 31 640,0 59 149,0
Total Liabilities 3,89 M 253 612,0 260 691,0
Shareholders' Equity -3,38 M -221 972,0 -201 542,0
Total Debt 1,14 M 200 000,0 200 000,0
Cash & Equivalents 58 404,0 — —
Current Assets 307 796,0 0,0 676,0
Current Liabilities 3,63 M 253 612,0 64 880,0